Options Brief: MannKind Corporation (MNKD)

Shares of MannKind Corporation MNKD are higher on the session by 5.15%, trading at $4.08. Overall put volume is now running at 2.79x the daily average, with 56% of all puts traded being purchases on the offer. 6,442 contracts have traded on the session so far. MannKind Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for diseases, such as diabetes and cancer.